23.01.2022, 673 Zeichen

Marinomed: Marinomed Biotech AG, an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, today announced that Dr. Cornelia Kutzer has been appointed as Chief Business Officer (CBO) of the company. As CBO, Dr. Kutzer will be responsible for further expanding Marinomed’s network of strategic partnerships both for product development and distribution in the therapeutic areas infectious diseases and immunology with an emphasis on ophthalmological indications.
Marinomed Biotech: weekly performance: 3.56%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (21/01/2022)

Christian Drastil: Wiener Börse Plausch

Zertifikate Party Österreich: Lars Reichel, Börse & Zertifikate aufs Ohr im gettex-Style (noch 7 Tage bis zum 20. Zertifikate Award 2026)

Bildnachweis

Aktien auf dem Radar:Mayr-Melnhof, Semperit, AT&S, Austriacard Holdings AG, Amag, Agrana, OMV, Marinomed Biotech, UBM, Rosgix, Bajaj Mobility AG, CA Immo, DO&CO, VIG, EuroTeleSites AG, Fabasoft, Frequentis, Wolford, Warimpex, Polytec Group, BKS Bank Stamm, CPI Europe AG, Österreichische Post, Telekom Austria, Scout24, IBM, salesforce.com, Fresenius Medical Care, Münchener Rück, Hannover Rück, BMW.

---